Of interest, the reduction of SOX2 and OCT4 expression in advanced-stage HNSCC, as reported in a study by Fu et al. [57], suggests that overexpression of SOX2 seen in early lesions might decrease gradually during tumor progression. The gene discussed is POU5F1; the disease is head and neck squamous cell carcinoma.